Newsfiscal.ai
Celularity Regains Compliance with Nasdaq Periodic Financial Reporting Requirement
· Published
Article summary
Celularity Inc. announced it has received confirmation from Nasdaq that it has regained compliance with the exchange's periodic financial reporting requirements following the filing of its second-quarter 2026 Form 10-Q.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…